PE Tech Report


Like this article?

Sign up to our free newsletter

Grant Avenue Capital adds MD to investment team

Grant Avenue Capital (Grant Avenue), a lower middle market healthcare-focused private equity firm, has appointed Brian Berkin as a managing director, effective immediately. Berkin will be responsible for sourcing and executing investments across Grant Avenue’s subsectors of focus, including Services, Devices, Pharma & Pharma Services, and HCIT.

A seasoned private equity professional with nearly 20 years of experience transacting across middle market healthcare, Berkin brings significant origination, due diligence, capital raising, and operations experience to Grant Avenue. Throughout the course of his career, he has worked hand-in-glove with management teams to successfully grow their businesses. At Grant Avenue, Berkin will help implement the firm’s portfolio company growth playbook which is based on six core tenets including human capital, operational efficiency, tech enablement, strategic sales and marketing, service or product line expansion, and M&A and de novos.

Prior to joining Grant Avenue, Berkin was a Partner at Tailwind Capital where he coordinated all aspects of the investment process, including developing investment theses, identifying investment talent, managing diligence, structuring transactions, and negotiating term sheets. Previously, he held roles at Chicago Pacific Founders, LLR Partners, and Roundtable Healthcare Partners. Berkin began his career in investment banking, serving as an analyst at Credit Suisse Group and Bear, Stearns & Co Inc. He earned a BA from the University of Michigan and a Master of Business Administration from The Wharton School at the University of Pennsylvania.

Like this article? Sign up to our free newsletter